Lupin, Mark Cuban Cost Plus Drug Company and COPD Foundation collaborate to expand access to medication for COPD patients Ruchika Sharma7 Sept 2023 11:10 AM ISTMumbai: Global pharma major Lupin Limited has forged a unique collaboration with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) and the COPD...
Lupin Gets CDSCO Panel Nod To Manufacture, Market FDC of Glycopyrronium, Vilanterol Inhalation Powder Dr. Divya Colin5 Sept 2023 6:00 PM ISTNew Delhi: The drug major Lupin has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Lupin, JnJ cut prices for TB drug in lower-income countries Ruchika Sharma1 Sept 2023 11:30 AM ISTThe drug will be available at the lower prices through the Stop TB Partnership's Global Drug Facility, which is the largest procurer of TB treatments.
Lupin arm unveils heart drug in Canada Ruchika Sharma31 Aug 2023 12:36 PM ISTMontreal: Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin Limited has announced the launch of Propranolol LA (long-acting) capsules, 60...
Submit interim analysis results of study in Russia and India: CDSCO panel Tells Lupin Over Aflibercept Dr. Divya Colin28 Aug 2023 6:00 PM ISTNew Delhi: In response to the proposal to enroll an additional 298 patients from India in the study of the ophthalmic drug Aflibercept, the Subject...
Lupin bags USFDA okay for idiopathic pulmonary fibrosis drug Pirfenidone Ruchika Sharma25 Aug 2023 2:33 PM ISTThis product will be manufactured at Lupin's Pithampur facility in India.
Lupin buys diabetes brands Ondero, Ondero Met from Boehringer Ingelheim International for Rs 235 Crore Ruchika Sharma19 Aug 2023 2:27 PM ISTMumbai: Global pharma major Lupin Limited has announced the acquisition of diabetes brands ONDERO and ONDERO MET, from Boehringer Ingelheim...
Lupin rolls out Tiotropium Bromide Inhalation Powder for COPD in US Ruchika Sharma17 Aug 2023 12:30 PM ISTMumbai: Pharma major Lupin Limited has announced the launch of Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, for the treatment of chronic ...
Lupin wins USFDA nod for Bromfenac Ophthalmic Solution Ruchika Sharma17 Aug 2023 11:00 AM ISTMumbai: Global pharma major Lupin Limited has announced that the company has received approval from the United States Food and Drug Administration...
Lupin gets USFDA approval for generic equivalent of Toprol XL Tablets Ruchika Sharma16 Aug 2023 3:29 PM ISTThis product will be manufactured at Lupin's Pithampur facility in India.
Lupin bags USFDA nod for Doxycycline Hyclate Delayed Release Tablets Ruchika Sharma14 Aug 2023 4:30 PM ISTMumbai: Global pharma major Lupin Limited today announced that the company has received approval from the United States Food and Drug Administration...
Lupin Mandideep facility successfully concludes USFDA inspection Ruchika Sharma14 Aug 2023 11:29 AM ISTMumbai: Global pharma major Lupin Limited has announced that its Unit-2 manufacturing facility located in Mandideep, India, has successfully...
